✓ Enriched with full company details from live data.
IndustryBiotechnology Research
Employees1-10
HeadquartersSan Jose, California, United States
Funding stageSeed
Total funding$1.5M
MIODx® is using its custom ClonoMap platform to profile an individual's adaptive immune system over time. The ultimate goal is to use T cell diversity as a prognostic tool to improve medical outcomes.
Technology stack
Click any tool to see other companies using it.
🔥 2 people from MIODx, Inc. are searchable on evyAI — names, titles, and unlockable contact info.
Also appears in these lists
- Top 100 Biotechnology Research in the United States — 9,440 companies